monoclonal-antibodies:-unlocking-cost-and-efficiency-gains-in-downstream-processing
Monoclonal Antibodies: Unlocking Cost and Efficiency Gains in Downstream Processing

Monoclonal Antibodies: Unlocking Cost and Efficiency Gains in Downstream Processing

Image of Kristina Pleitt

Kristina Pleitt

Senior Staff Scientist
Thermo Fisher Scientific

Panelist

Image of Kristina Pleitt

Kristina Pleitt

Kristina Pleitt is a senior staff scientist at Thermo Fisher Scientific with 15 years of experience in biopharmaceutical process development and manufacturing. Her expertise includes downstream process development, process scale-up, integrated continuous processing, and clinical and commercial production, with a particular focus on advancing intensified downstream strategies that improve process efficiency, performance, and manufacturability.

Broadcast Date: 

  • Time: 

Analytical developers and downstream scientists are under constant pressure to improve process efficiency while maintaining product quality for monoclonal antibodies (mAbs). Yet, many platform purification processes still leave untapped opportunities for optimization, cost reduction, and simplification.

In this webinar, our speaker will explore a series of practical, chromatography-focused strategies designed to enhance mAb purification performance while reducing cost of goods (COGs). Using real-world examples and process scenarios, attendees will gain insight into:

  • Identifying opportunities to simplify traditional mAb purification workflows
  • Improving Protein A performance and lifetime to drive cost savings
  • Enabling efficient two-step downstream processes through better impurity management
  • Addressing difficult HCP and aggregate clearance challenges with advanced polishing strategies

A live Q&A session will follow the presentation, offering you a chance to engage directly with our expert and discuss how these approaches can be applied to your own processes.

Produced with support from:

Thermo Fisher logo